T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 6 II, 1998, Pages 953-960

  Sánchez Segura, Antonio ^a   Brieva, José A ^b   Rodríguez, Carmen ^b  

^a HOSPITAL DE JEREZ   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Cytokines; Human; IFN ; IL 5; Inflammation; Lymphocytes; Nasal polyps; Phenotype; T lymphocytes

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 5; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MALE; MEMORY CELL; NOSE DISEASE; NOSE POLYP; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0032433669     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(98)70333-1     Document Type: Article

References (38)

1. Jankowski R, Béné MC, Moneret-Vautrin AD, Haas F, Faure G, Simon C, et al. Immunohistological characteristic of nasal polyps. Rhinology 1989;(Suppl 8):51-8.
2. Jones E, Frenkiel S, Small P, Rochon L. Immunopathological characteristics of nasal polyps. J Otolaryngol 1987;16:19-22.
3. Small P, Frenkiel S, Black M. Multifactorial etiology of nasal Polyps. Ann Allergy 1981;46:317-20.
4. Hosemann W, Goede U, Wagner W. Epidemiology, pathogenesis of nasal polyposis and spectrum of endonasal sinus surgery. Am J Otolaryngol 1994;15:85-98.
5. Bernstein JM, Gorfien J, Noble B. Role of allergy in nasal polyposis: a review. Arch Otolaryngol Head Neck Surg 1995;113:724-32.
6. Larocca LM, Maggiano N, Capelli A, Bevilacqua P, Ruscito P, Maurizi M, et al. Immunopathology of nasal polyps: an immunohistochemical approach. Ann Allergy 1989;63:508-12.
7. Stoop AE, Van der Heijden HA, Biewenga J, Van der Van S. Lymphocytes and nonlymphoid cells in human nasal polyps. J Allergy Clin Immunol 1991;87:470-5.
8. Linder A, Karlsson-Parra A, Hirvela C, Jonsson L, Koling A, Sjoberg O. Immunocompetent cells in human nasal polyps and normal mucosa. Rhinology 1993;31:125-9.
9. Liu CM, Shun CT, Hsu MM. Lymphocyte subsets and antigen-specific IgE antibody in nasal polyps. Ann Allergy 1994;72:19-24.
10. Symon FA, Walsh GM, Watson SR, Wardlaw AJ. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J Exp Med 1994;180:371-6.
11. Medina F, Segundo C, Rodríguez C, Brieva JA. Regulatory role of CD95 ligation on human B cells induced in vivo capable of spontaneous and high-rate Ig secretion. Eur J Immunol 1997;27:700-6.
12. Dhein J, Walczak H, Baümler C, Debatin K-M, Krammer PH. Autocrine T-cell suicide mediated by APO-1/Fas (CD95). Nature 1995;373:438-41.
13. Schmid I, Uitenbogaart CH, Keld B, Giorgi JV. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser cytometry. J Immunol Methods 1994;170:145-57.
14. Swain SL, Croft M, Dubey C, Haynes L, Rogers P, Zhang X, et al. From naive to memory T cells. Immunol Rev 1996;150:143-67.
15. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima SY, Samachima M, et al. The polypeptide encoded by the cDNA for human cell surface antigen FAS can mediate apoptosis. Cell 1991;66:233-43.
16. Stoop AE, Van der Heijden HA, Biewenga J, Van der Baan S. Clinical aspects and distribution of immunologically active cells in the nasal mucosa of patients with nasal polyps after endoscopic sinus surgery and treatment with topical corticosteroids. Eur Arch Otorhinolaryngol 1992;249:313-7.
17. Croft M, Bradley LM, Swain SL. Naive versus memory CD4 T cell response to antigen. J Immunol 1994;152:2675-85.
18. Dubey C, Croft M, Swain SL. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J Immunol 1996;157:3280-9.
19. Baars PA, Maurice MM, Rep M, Hooibrink B, van Lier RAW. Heterogeneity of the circulating human CD4+ T cell population. J Immunol 1995;154:17-25.
20. Laffon A, García-Vicuña R, Humbría A, Postigo AA, Corbi AL. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J Clin Invest 1988;88:546-52.
21. García-Monzón C, Moreno-Otero R, Pajares JM, García-Sánchez A, López-Botet M, de Landázuri O, et al. Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis. Gastroenterology 1990;98:1029-35.
22. Hoi BEA, Hintzen RQ, van Lier RAW, Alberts C, Out TA, Jansen HM. Soluble and cellular markers of T-cell activation in patients with pulmonary sarcoidosis. Am Rev Respir Dis 1993;148:643-9.
23. Marazuela M, Postigo AA, Acevedo A, Díaz-Gonzalez F, Sánchez-Madrid F, de Landázuri OM. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands. Eur J Immunol 1994;24:2483-90.
24. Fuss IJ, Neurath M, Boirivant M, Klein JS, De la Motte C, Strong SA, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J. Immunol. 1996;157:1261-70.
25. Brezinschek RI, Lipsky PE, Galea R Vita R, Oppenheimer-Marks N. Phenotypic characterization of CD4+ T cells that exhibit a transendothelial migratory capacity. J Immunol 1995;154:3062-77.
26. Bradley LM, Watson SR, Swain SL. Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin. J Exp Med 1994;180:2401-6.
27. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, Terstappen LWMM. Control of lymphocyte recirculation in man (I). J Immunol 1993;150:1105-21.
28. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, Terstappen LWMM. Control of lymphocyte recirculation in man (II). J Immunol 1993;150:1122-36.
29. Cerf-Bensussan N, Jarry A, Brousse N, Lisowska-Grospierre B, Guy-Grand D, Griscelli C. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol 1987;17:1279-85.
30. Schieferdecker HL, Ullrich R, Hirseland H, Zeitz M. T-cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J Immunol 1992;149:2816-22.
31. Nagata S, Goldstein P. The fas death factor. Science 1995;267:1449-62.
32. De Maria R, Boirivant M, Cifone MG, Roncaioli P, Hahne M, Tschopp J, et al. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J Clin Invest 1996;97:316-22.
33. Miller CH, Pudiak DR, Hatem F, Looney RJ. Accumulation of interferon gamma-producing Th1 helper cells in nasal polyps. Otolaryngol Head Neck Surg 1994;111:51-8.
34. Dellacomo FR, Eisma R, Lafreniere D, Leonard G, Kreutzer D. Interferonγ expression in human nasal polyps. Laryngoscope. 1997;107:626-30.
35. Min Y-G, Lee CH, Rhee CS, Kim KH, Kim CS, Koh YY, et al. Inflammatory cytokine expression on nasal polyps developed in allergic and infectious rhinitis. Acta Otolaryngol (Stockh) 1997;117:302-6.
36. Hamilos DL, Leung DY, Wood R, Cunningham L, Bean DK, Yasruel Z, et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995;96:537-44.
37. Simon HU, Yousefi S, Schranz C, Schopowal A, Bacchert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-8.
38. Bachert C, Wagenmann M, Hauser U, Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997;99:837-42.